{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T23:08:25Z","timestamp":1789600105311,"version":"build-2803163510"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100018546","name":"Postdoctoral Innovation Project of Shandong Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100018546","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["91743113"],"award-info":[{"award-number":["91743113"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81903354"],"award-info":[{"award-number":["81903354"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["91943301"],"award-info":[{"award-number":["91943301"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2017YFC1600200"],"award-info":[{"award-number":["2017YFC1600200"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2020M672008"],"award-info":[{"award-number":["2020M672008"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.bcp.2021.114582","type":"journal-article","created":{"date-parts":[[2021,4,23]],"date-time":"2021-04-23T02:43:54Z","timestamp":1619145834000},"page":"114582","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["A novel epigenetic mechanism unravels hsa-miR-148a-3p-mediated CYP2B6 downregulation in alcoholic hepatitis disease"],"prefix":"10.1016","volume":"188","author":[{"given":"Jiao","family":"Luo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengyue","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yufei","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanli","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuanhai","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunming","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ningning","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanan","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianqian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxin","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dianke","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.bcp.2021.114582_b0005","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1021\/tx500444e","article-title":"Survey of human oxidoreductases and cytochrome P450 enzymes involved in the metabolism of xenobiotic and natural chemicals","volume":"28","author":"Rendic","year":"2015","journal-title":"Chem. Res. Toxicol."},{"issue":"5","key":"10.1016\/j.bcp.2021.114582_b0010","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1074\/jbc.TM118.004144","article-title":"Cytochrome P450 research and The Journal of Biological Chemistry","volume":"294","author":"Guengerich","year":"2019","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2021.114582_b0015","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.tox.2016.11.014","article-title":"Comparison of xenobiotic-metabolising human, porcine, rodent, and piscine cytochrome P450","volume":"375","author":"Burkina","year":"2017","journal-title":"Toxicology"},{"issue":"12","key":"10.1016\/j.bcp.2021.114582_b0020","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0082562","article-title":"Polymorphic cytochrome P450 enzymes (CYPs) and their role in personalized therapy","volume":"8","author":"Preissner","year":"2013","journal-title":"PLoS ONE"},{"issue":"1","key":"10.1016\/j.bcp.2021.114582_b0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cld.2016.08.001","article-title":"Drug Metabolism in the Liver","volume":"21","author":"Almazroo","year":"2017","journal-title":"Clin. Liver Dis."},{"issue":"1","key":"10.1016\/j.bcp.2021.114582_b0030","doi-asserted-by":"crossref","first-page":"38","DOI":"10.2174\/1389450118666170125144557","article-title":"Cytochrome P450 structure, function and clinical significance: a review","volume":"19","author":"Manikandan","year":"2018","journal-title":"Curr. Drug Targets"},{"issue":"4","key":"10.1016\/j.bcp.2021.114582_b0035","doi-asserted-by":"crossref","first-page":"276","DOI":"10.2174\/1568026619666190129122727","article-title":"Xenobiotic metabolising enzymes: impact on pathologic conditions, drug interactions and drug design","volume":"19","author":"Rekka","year":"2019","journal-title":"Curr. Top. Med. Chem."},{"issue":"9","key":"10.1016\/j.bcp.2021.114582_b0040","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.2174\/138920012803341302","article-title":"Drug disposition in pathophysiological conditions","volume":"13","author":"Gandhi","year":"2012","journal-title":"Curr. Drug Metab."},{"issue":"1","key":"10.1016\/j.bcp.2021.114582_b0045","doi-asserted-by":"crossref","first-page":"4","DOI":"10.2174\/138920010791110917","article-title":"Update information on drug metabolism systems\u20132009, part II: summary of information on the effects of diseases and environmental factors on human cytochrome P450 (CYP) enzymes and transporters","volume":"11","author":"Rendic","year":"2010","journal-title":"Curr. Drug Metab."},{"issue":"9","key":"10.1016\/j.bcp.2021.114582_b0050","doi-asserted-by":"crossref","first-page":"3459","DOI":"10.1128\/AAC.00791-07","article-title":"Altered pharmacokinetics of voriconazole in a patient with liver cirrhosis","volume":"51","author":"Weiler","year":"2007","journal-title":"Antimicrob. Agents Chemother."},{"issue":"4","key":"10.1016\/j.bcp.2021.114582_b0055","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.cld.2013.07.013","article-title":"Hepatotoxicity and drug interactions in liver transplant candidates and recipients","volume":"17","author":"Parikh","year":"2013","journal-title":"Clin. Liver Dis"},{"issue":"4","key":"10.1016\/j.bcp.2021.114582_b0060","doi-asserted-by":"crossref","first-page":"299","DOI":"10.2165\/00003495-197918040-00003","article-title":"Drug interactions with alcohol","volume":"18","author":"Linnoila","year":"1979","journal-title":"Drugs"},{"issue":"4","key":"10.1016\/j.bcp.2021.114582_b0065","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/BF00607680","article-title":"Histological changes in the liver and indices of drug metabolism in alcoholics","volume":"11","author":"Sotaniemi","year":"1977","journal-title":"Eur. J. Clin. Pharmacol."},{"issue":"1","key":"10.1016\/j.bcp.2021.114582_b0070","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/BF00606684","article-title":"Liver size and indices of drug metabolism in alcoholics","volume":"13","author":"Pirttiaho","year":"1978","journal-title":"Eur. J. Clin. Pharmacol."},{"issue":"1","key":"10.1016\/j.bcp.2021.114582_b0075","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/clpt.1986.138","article-title":"Fibrotic process and drug metabolism in alcoholic liver disease","volume":"40","author":"Sotaniemi","year":"1986","journal-title":"Clin. Pharmacol. Ther."},{"issue":"2","key":"10.1016\/j.bcp.2021.114582_b0080","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1136\/flgastro-2018-101104","article-title":"Recent advances in alcoholic hepatitis","volume":"11","author":"Veryan","year":"2020","journal-title":"Frontl. Gastroenterol."},{"issue":"7","key":"10.1016\/j.bcp.2021.114582_b0085","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/nrg3965","article-title":"Towards a molecular understanding of microRNA-mediated gene silencing","volume":"16","author":"Jonas","year":"2015","journal-title":"Nat. Rev. Genet."},{"issue":"5","key":"10.1016\/j.bcp.2021.114582_b0090","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1080\/17425255.2018.1472237","article-title":"Current knowledge of microRNA-mediated regulation of drug metabolism in humans","volume":"14","author":"Nakano","year":"2018","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"10.1016\/j.bcp.2021.114582_b0095","doi-asserted-by":"crossref","unstructured":"D. Li, W.H. Tolleson, D. Yu, S. Chen, L. Guo, W. Xiao, W. Tong, B. Ning, MicroRNA-Dependent Gene Regulation of the Human Cytochrome P450, (2019) 129-138.","DOI":"10.1016\/B978-0-12-813939-4.00004-8"},{"issue":"11","key":"10.1016\/j.bcp.2021.114582_b0100","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.2217\/bmm.15.89","article-title":"microRNAs as pharmacogenomic biomarkers for drug efficacy and drug safety assessment","volume":"9","author":"Koturbash","year":"2015","journal-title":"Biomarkers Med."},{"key":"10.1016\/j.bcp.2021.114582_b0105","doi-asserted-by":"crossref","first-page":"8534","DOI":"10.1038\/srep08534","article-title":"Suppression of CYP2C9 by microRNA hsa-miR-128-3p in human liver cells and association with hepatocellular carcinoma","volume":"5","author":"Yu","year":"2015","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.bcp.2021.114582_b0110","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.bcp.2015.08.094","article-title":"MicroRNA hsa-miR-29a-3p modulates CYP2C19 in human liver cells","volume":"98","author":"Yu","year":"2015","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bcp.2021.114582_b0115","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.bcp.2016.06.007","article-title":"MicroRNA hsa-miR-25-3p suppresses the expression and drug induction of CYP2B6 in human hepatocytes","volume":"113","author":"Jin","year":"2016","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bcp.2021.114582_b0120","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.bcp.2017.05.018","article-title":"MicroRNA hsa-miR-370-3p suppresses the expression and induction of CYP2D6 by facilitating mRNA degradation","volume":"140","author":"Zeng","year":"2017","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bcp.2021.114582_b0125","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.bcp.2017.08.012","article-title":"The expression, induction and pharmacological activity of CYP1A2 are post-transcriptionally regulated by microRNA hsa-miR-132-5p","volume":"145","author":"Chen","year":"2017","journal-title":"Biochem. Pharmacol."},{"issue":"9","key":"10.1016\/j.bcp.2021.114582_b0130","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1136\/gutjnl-2015-311314","article-title":"Integrative microRNA profiling in alcoholic hepatitis reveals a role for microRNA-182 in liver injury and inflammation","volume":"65","author":"Blaya","year":"2016","journal-title":"Gut"},{"issue":"4","key":"10.1016\/j.bcp.2021.114582_b0135","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1136\/gutjnl-2017-315123","article-title":"Alcohol dysregulates miR-148a in hepatocytes through FoxO1, facilitating pyroptosis via TXNIP overexpression","volume":"68","author":"Heo","year":"2019","journal-title":"Gut"},{"key":"10.1016\/j.bcp.2021.114582_b0140","article-title":"A novel mechanism underlying alcohol dehydrogenase expression: hsa-miR-148a-3p promotes ADH4 expression via an AGO1-dependent manner in control and ethanol-exposed hepatic cells","volume":"114458","author":"Luo","year":"2021","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bcp.2021.114582_b0145","article-title":"Biotin-based pulldown assay to validate mRNA targets of cellular miRNAs","volume":"136","author":"Dash","year":"2018","journal-title":"J. Vis. Exp."},{"issue":"4","key":"10.1016\/j.bcp.2021.114582_b0150","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1007\/s00018-016-2377-9","article-title":"microRNA-122 target sites in the hepatitis C virus RNA NS5B coding region and 3' untranslated region: function in replication and influence of RNA secondary structure","volume":"74","author":"Gerresheim","year":"2017","journal-title":"Cell. Mol. Life Sci. CMLS"},{"key":"10.1016\/j.bcp.2021.114582_b0155","doi-asserted-by":"crossref","first-page":"9453","DOI":"10.1038\/srep09453","article-title":"Re-annotation of presumed noncoding disease\/trait-associated genetic variants by integrative analyses","volume":"5","author":"Chen","year":"2015","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.bcp.2021.114582_b0160","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1021\/tx700079z","article-title":"Cytochrome p450 and chemical toxicology","volume":"21","author":"Guengerich","year":"2008","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.bcp.2021.114582_b0165","first-page":"1","article-title":"A history of the roles of cytochrome P450 enzymes in the toxicity of drugs","author":"Guengerich","year":"2020","journal-title":"Toxicol. Res."},{"issue":"3854","key":"10.1016\/j.bcp.2021.114582_b0170","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1126\/science.162.3854.690","article-title":"Hepatic microsomal enzymes in man and rat: induction and inhibition by ethanol","volume":"162","author":"Rubin","year":"1968","journal-title":"Science"},{"issue":"5 Pt 2","key":"10.1016\/j.bcp.2021.114582_b0175","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1002\/cpt1977225part2735","article-title":"Drug metabolism in heavy consumers of ethyl alcohol","volume":"22","author":"Iber","year":"1977","journal-title":"Clin. Pharmacol. Ther."},{"issue":"2","key":"10.1016\/j.bcp.2021.114582_b0180","doi-asserted-by":"crossref","first-page":"164","DOI":"10.2174\/138920009787522151","article-title":"Role of NF-kappaB in the regulation of cytochrome P450 enzymes","volume":"10","author":"Zordoky","year":"2009","journal-title":"Curr. Drug Metab."},{"issue":"7","key":"10.1016\/j.bcp.2021.114582_b0185","doi-asserted-by":"crossref","first-page":"730","DOI":"10.2174\/138920009789895534","article-title":"Substrate specificity, regulation, and polymorphism of human cytochrome P450 2B6","volume":"10","author":"Mo","year":"2009","journal-title":"Curr. Drug Metab."},{"issue":"1","key":"10.1016\/j.bcp.2021.114582_b0190","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.pharmthera.2012.12.007","article-title":"Cytochrome P450 enzymes in drug metabolism: regulation of gene expression, enzyme activities, and impact of genetic variation","volume":"138","author":"Zanger","year":"2013","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.bcp.2021.114582_b0195","article-title":"Mechanisms of miRNA-mediated gene regulation from common downregulation to mRNA-specific upregulation","volume":"2014","author":"Valinezhad Orang","year":"2014","journal-title":"Int. J. Genom."},{"issue":"4","key":"10.1016\/j.bcp.2021.114582_b0200","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/nrg3162","article-title":"MicroRNAs and their targets: recognition, regulation and an emerging reciprocal relationship","volume":"13","author":"Pasquinelli","year":"2012","journal-title":"Nat. Rev. Genet."},{"issue":"2","key":"10.1016\/j.bcp.2021.114582_b0205","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.molcel.2016.09.004","article-title":"Pairing beyond the seed supports MicroRNA targeting specificity","volume":"64","author":"Broughton","year":"2016","journal-title":"Mol. Cell"},{"issue":"3","key":"10.1016\/j.bcp.2021.114582_b0210","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.tig.2018.12.005","article-title":"miRNA targeting: growing beyond the seed","volume":"35","author":"Chipman","year":"2019","journal-title":"Trends Genet."},{"key":"10.1016\/j.bcp.2021.114582_b0215","doi-asserted-by":"crossref","DOI":"10.1038\/emm.2016.3","article-title":"miR-148a is a downstream effector of X-box-binding protein 1 that silences Wnt10b during adipogenesis of 3T3-L1 cells","volume":"48","author":"Cho","year":"2016","journal-title":"Exp. Mol. Med."},{"issue":"3","key":"10.1016\/j.bcp.2021.114582_b0220","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1053\/jhep.2001.22176","article-title":"Cytochrome P450 regulation by hepatocyte nuclear factor 4 in human hepatocytes: a study using adenovirus-mediated antisense targeting","volume":"33","author":"Jover","year":"2001","journal-title":"Hepatology"}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000629522100188X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000629522100188X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T01:14:42Z","timestamp":1778634882000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000629522100188X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":44,"alternative-id":["S000629522100188X"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2021.114582","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A novel epigenetic mechanism unravels hsa-miR-148a-3p-mediated CYP2B6 downregulation in alcoholic hepatitis disease","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2021.114582","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"114582"}}